Skip to main content
. Author manuscript; available in PMC: 2017 Sep 1.
Published in final edited form as: Psychopharmacology (Berl). 2016 Jul 4;233(17):3161–3172. doi: 10.1007/s00213-016-4360-4

Figure 8. Naloxone CPA.

Figure 8

Levels of pSer845-GluA1, pERK1, pERK2 and corresponding total proteins in nucleus accumbens core (left) and shell (right) of ad libitum fed (AL) and food-restricted (FR) rats sacrificed immediately after the final naloxone CPA test. Results (mean ± s.e.m.) are expressed in comparison to the normalized control, defined as the ad libitum fed (AL) group. Representative immunoblots are included beneath each bar graph. *p<.05